发明名称 |
INJECTABLE FORMULATIONS CONTAINING SUCCINATE |
摘要 |
The invention is directed to formulations of a pharmaceutically active agent for in vivo use. The formulations to which the invention is directed are designed to minimize the pain associated with components in injectable formulations, other than the pharmaceutically active agent. The invention is particularly directed to buffers that provide for minimum pain upon injection. Insulin-like growth factor I (IGF-I) is a preferred pharmaceutically active agent.
|
申请公布号 |
US2007249522(A1) |
申请公布日期 |
2007.10.25 |
申请号 |
US20070773184 |
申请日期 |
2007.07.03 |
申请人 |
NOVARTIS VACCINES & DIAGNOSTICS, INC. |
发明人 |
SHIRLEY BRET A.;HORA MANINDER S. |
分类号 |
A61K38/30;A61K9/00;A61K9/08;A61K31/21;A61K38/22;A61K38/28;A61K47/12 |
主分类号 |
A61K38/30 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|